Rifaximin tablets are indicated for reducing the risk of overt hepatic encephalopathy (HE) recurrence and to treat irritable ...
Capital Market on MSN
Biocon Pharma receives USFDA approval for Rifaximin Tablets
Biocon Pharma, a wholly owned subsidiary of the Company, in partnership with Carnegie Pharmaceuticals LLC, received tentative approval from the U.S. Food and Drug Administration (U.S. FDA) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback